Sign Up to like & get
recommendations!
1
Published in 2019 at "Molecular immunology"
DOI: 10.1016/j.molimm.2019.04.030
Abstract: Multiepitope cancer vaccines are announcing themselves as the future of melanoma treatment. Herein, high immunogenic regions of transmembrane protein 31 (TMEM31) antigen were selected according to cytotoxic T lymphocytes' (CTL) epitopes and major histocompatibility complex…
read more here.
Keywords:
tmem31 antigen;
protein tmem31;
multiepitope;
cancer ... See more keywords